ACS Medicinal Chemistry Letters p. 1185 - 1190 (2020)
Update date:2022-08-29
Topics:
Bloomfield, Graham
Booker-Milburn, Kevin I.
Cox, Brian
Cox, Philip B.
Elliott, Luke D.
Paumier, Romain
Robertson-Ralph, Michael
Zdorichenko, Victor
The pressure to deliver new medicines to the patient continues to grow along with increases in compound failure rate, thus putting the current R&D model at risk. Analysis has shown that increasing the three-dimensionality of potential drug candidates decreases the risk of failure and improves binding selectivity and frequency. For this reason many workers have taken a new look at the power of photochemistry as a means to generate novel sp3 rich scaffolds for use in drug discovery programs. Here we report the design, synthesis, and computational structural analysis of a series of 2,4-methanoprolines having inherent 3D character (PMI and PBF scores) significantly higher than that of the broader AbbVie Rule of 3 (Ro3) collection.
View MoreHangzhou Showland Technology Co., Ltd.
Contact:86-571-88920516
Address:ROOM2118,NO.553,WENSAN ROAD,HANGZHOU,CHINA
Dongguan Albiya Energy Science and Technology Co.,Ltd
Contact:+86-769-22181286
Address:Huanan Industial Park, Dongguan,China
Jewim Pharmaceutical (Shandong) Co., Ltd
Contact:+8615621883869
Address:山东省泰安市高新技术产业开发区配天门大街西首
Zhejiang Allied Chemical Co.,Ltd
Contact:18967038207
Address:Area A-30, High-tech Industrial Park, Quzhou, Zhejiang, China.
Zibo Ocean International Trade Co.,Ltd
Contact:+86 533 5160706
Address:1117, Hongtai Bld., Songling rd, Zichuan,Zibo,Shandong,China
Doi:10.1016/0021-9517(86)90359-3
(1986)Doi:10.1055/s-0029-1217132
(2010)Doi:10.1021/jo00175a001
(1984)Doi:10.1016/j.tetlet.2004.10.007
(2004)Doi:10.1080/10426507.2015.1135151
(2016)Doi:10.1055/s-1975-23797
(1975)